Thermo Fisher (TMO) Raises 2.1 Billion Through Floating and Fixed-Rate Senior Notes

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the best dividend stocks to buy according to hedge funds. On November 25, Thermo Fisher reported that it had made an offering of euro-dominated notes in the principal amount of €2.1 billion. The notes are planned to be issued via  Thermo Fisher Scientific (Finance I) B.V., the company’s indirect finance subsidiary.

The company is planning to issue €1 billion worth of floating-rate senior notes due in 2027 at their full principal amount. It will also issue €1.1 billion of 3.628% fixed-rate senior notes due in 2035, again at full principal value. The offering is set to conclude on or near December 1, 2025, after all conditions are fulfilled. The notes will be entirely guaranteed by Thermo Fisher. While the floating rate notes deliver quarterly interest payments, the fixed rate notes will offer yearly interest payouts.

Thermo Fisher aims to utilize the net proceeds from the offering for corporate expenditure, such as acquisitions, debt repayment, working capital, capital expenditures, or share repurchases, or invest them in short-term, high liquidity assets.

Separately, on November 3, Daniel Arias from Stifel Nicolaus kept a Buy recommendation on Thermo Fisher, with an accompanying price target of $583.

Thermo Fisher Scientific Inc. (NYSE:TMO) is a Massachusetts-based company that manufactures and distributes life sciences products, lab equipment, and biopharma services worldwide.

While we acknowledge the potential of TMO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: Dow 20 Stocks List: Ranked By Hedge Fund Bullishness Index and 10 Unstoppable Dividend Stocks to Buy Now.

Disclosure. None.